Helping Hospital Infection Control: reOpenTest's Reliable C. difficile Testing Solutions
Clostridium difficile (C. difficile) is one of the main pathogens causing healthcare-associated infections (HAI), posing a serious challenge to patient safety and medical costs. Learn how our high-quality GDH and Toxin A/B rapid test reagents can help your hospital customers effectively perform C. diff screening and diagnosis, implement precise infection control measures, and curb nosocomial transmission.
Get a Quote for C. diff Testing ProductsC. difficile: A Severe Challenge for Hospital Infection Control
The Main Cause of Nosocomial Infections
C. difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea and pseudomembranous colitis, significantly increasing patients' length of stay, risk of complications, and medical expenses.
Easy to Spread, Difficult to Control
C. difficile spores are extremely resistant to the environment and can spread rapidly within healthcare facilities through contact with patients or contaminated environmental surfaces, posing a huge challenge to infection control.
Rapid Diagnosis is Crucial
Timely and accurate identification of CDI patients is the key to taking effective isolation measures, guiding rational drug use, and cutting off transmission routes, which is essential for improving patient prognosis and controlling outbreaks.
reOpenTest C. difficile Testing Solutions: Reliable and Efficient
Glutamate Dehydrogenase (GDH) Antigen Test
GDH is an enzyme commonly produced by C. difficile. Our GDH antigen rapid test has high sensitivity and is an ideal screening tool that can quickly rule out negative samples, effectively reduce subsequent unnecessary toxin testing, and optimize the testing process.
Learn MoreToxin A/B Antigen Test
Directly detects the key pathogenic factors causing CDI clinical symptoms - Toxin A and/or Toxin B. This test has high specificity and is an important basis for confirming active CDI infection and guiding clinical treatment.
Learn MoreGDH / Toxin A/B Combo Test
Integrates high-sensitivity GDH screening with high-specificity toxin confirmation on a single test strip. Screening and confirmation results can be obtained simultaneously in one step, greatly simplifying the operation process and improving laboratory diagnostic efficiency.
Learn MorereOpenTest C. difficile series of test reagents are easy to operate, reliable results can be obtained within 15 minutes, and have passed strict quality control and clinical verification.
Clinically Validated Reliable Performance
Our C. difficile test reagents have undergone extensive clinical evaluation and have shown excellent performance compared to gold standard methods (such as cytotoxin neutralization assay CTNA, toxin gene PCR). The following is a summary of some performance data:
| Test Item | Sensitivity (%) | Specificity (%) | Comparison Method |
|---|---|---|---|
| GDH Antigen Test | ≥95% | ≥98% | Toxin Gene PCR / Anaerobic Culture |
| Toxin A/B Antigen Test | ≥92% | ≥99% | Cytotoxin Neutralization Assay (CTNA) / Toxin Gene PCR |
*Specific performance data may vary slightly depending on the sample type and comparison method. Please refer to the corresponding product instructions or contact us for a complete clinical evaluation report for detailed information.
Empowering Distributors: How to Promote reOpenTest C. diff Testing to Your Hospital Customers?
- Emphasize Infection Control Value:Highlight the critical role of rapid and accurate C. diff testing in early identification, patient isolation, treatment guidance, and prevention of nosocomial outbreaks.
- Promote the Two-Step Strategy:Explain the clinical significance and cost-effectiveness of combining GDH as an efficient screening tool (high negative predictive value) with Toxin A/B as a confirmation tool (high positive predictive value).
- Provide Reliable Evidence:Showcase the product's excellent sensitivity and specificity data, as well as qualifications such as CE certification, to enhance the confidence of clinical laboratories and infectious disease physicians in product quality.
- Combine Guidelines and Practice:Cite relevant national or regional CDI diagnostic guidelines and hospital infection control best practices to illustrate how reOpenTest products meet or exceed these requirements.
- Provide a Complete Solution:Not only provide test reagents, but also provide related operation training and technical support to become a reliable partner for hospital infection control.
Help Hospital Customers, Win the Infection Control Market
Choose reOpenTest's high-quality, high-performance C. difficile test reagents to provide your hospital customers with a powerful weapon against nosocomial infections. We are committed to providing comprehensive support to our distributor partners. Contact us now to learn more about product details and partnership policies.